Fluarix Tetra

Fluarix Tetra is a quadrivalent influenza vaccine designed to protect against four strains of the flu virus. This vaccine is administered intramuscularly and is manufactured by Glaxosmithkline Biologicals S.A.

Fluarix Tetra is used to prevent influenza caused by the B/Phuket/3073/2013-like virus and the Influenza Virus B/Austria/1359417/2020. It is typically administered to individuals who are at risk of contracting the flu, including those who are in close contact with infected individuals or those who are in high-risk groups. The vaccine is intended to provide immunity against these specific strains of the influenza virus.

Common effects of Fluarix Tetra may include soreness at the injection site, mild fever, and muscle aches. These effects are generally mild and short-lived. Some individuals may also experience fatigue or headache following vaccination.

Fluarix Tetra should be administered with caution in individuals with a history of severe allergic reactions to previous influenza vaccines or any of the components in the vaccine. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. The vaccine should be stored and handled according to the manufacturer's guidelines to ensure its effectiveness.

Fluarix Tetra may interact with certain medications or other vaccines. It is important to inform your healthcare provider about all medications you are taking before receiving the vaccine. Additionally, the vaccine should not be administered concurrently with other live vaccines without consulting a healthcare professional.